Cargando…
Retraction: Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma
Autores principales: | Liu, Ping, Sun, Liang, Zhou, Dong-sheng, Zhang, Peng, Wang, Yong-hui, Li, Dong, Li, Qing-hu, Feng, Rong-jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025640/ https://www.ncbi.nlm.nih.gov/pubmed/27633088 http://dx.doi.org/10.1038/srep31938 |
Ejemplares similares
-
Development of Alendronate-conjugated Poly (lactic-co-glycolic acid)-Dextran Nanoparticles for Active Targeting of Cisplatin in Osteosarcoma
por: Liu, Ping, et al.
Publicado: (2015) -
Ifosfamide-loaded poly (lactic-co-glycolic acid) PLGA-dextran polymeric nanoparticles to improve the antitumor efficacy in Osteosarcoma
por: Chen, Bin, et al.
Publicado: (2015) -
Retraction Note: Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of Osteosarcoma
por: Qin, Yan-Guo, et al.
Publicado: (2020) -
Fabrication and characterization of hydrocortisone loaded Dextran-Poly Lactic-co-Glycolic acid micelle
por: Malekhosseini, Shifteh, et al.
Publicado: (2020) -
Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
Publicado: (2019)